Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CARE vs UVSP

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CARE
Carter Bankshares, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$580M
5Y Perf.+270.7%
UVSP
Univest Financial Corporation

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$1.10B
5Y Perf.+135.8%

CARE vs UVSP — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CARE logoCARE
UVSP logoUVSP
IndustryBanks - RegionalBanks - Regional
Market Cap$580M$1.10B
Revenue (TTM)$255M$518M
Net Income (TTM)$31M$91M
Gross Margin61.7%61.0%
Operating Margin15.7%21.9%
Forward P/E4.8x11.1x
Total Debt$179M$352M
Cash & Equiv.$105M$554M

CARE vs UVSPLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CARE
UVSP
StockMay 20May 26Return
Carter Bankshares, … (CARE)100370.7+270.7%
Univest Financial C… (UVSP)100235.8+135.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CARE vs UVSP

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CARE leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Univest Financial Corporation is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
CARE
Carter Bankshares, Inc.
The Banking Pick

CARE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 0 yrs, beta 0.56
  • Rev growth 6.2%, EPS growth 32.1%
  • Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
Best for: income & stability and growth exposure
UVSP
Univest Financial Corporation
The Banking Pick

UVSP is the clearest fit if your priority is long-term compounding and bank quality.

  • 141.5% 10Y total return vs CARE's 111.1%
  • NIM 2.8% vs CARE's 2.7%
  • Efficiency ratio 0.4% vs CARE's 0.5% (lower = leaner)
Best for: long-term compounding and bank quality
See the full category breakdown
CategoryWinnerWhy
GrowthCARE logoCARE6.2% NII/revenue growth vs UVSP's 3.6%
ValueCARE logoCARELower P/E (4.8x vs 11.1x)
Quality / MarginsUVSP logoUVSPEfficiency ratio 0.4% vs CARE's 0.5% (lower = leaner)
Stability / SafetyCARE logoCAREBeta 0.56 vs UVSP's 1.01
DividendsUVSP logoUVSP2.3% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)CARE logoCARE+68.4% vs UVSP's +32.7%
Efficiency (ROA)UVSP logoUVSPEfficiency ratio 0.4% vs CARE's 0.5%

CARE vs UVSP — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CARECarter Bankshares, Inc.
FY 2025
Bank Owned Life Insurance Income
74.0%$2M
Other Revenue
26.0%$532,000
UVSPUnivest Financial Corporation
FY 2025
Investment Advice
44.2%$23M
Financial Service, Other
21.2%$11M
Deposit Account
17.4%$9M
Fiduciary and Trust
17.2%$9M

CARE vs UVSP — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUVSPLAGGINGCARE

Income & Cash Flow (Last 12 Months)

UVSP leads this category, winning 4 of 5 comparable metrics.

UVSP is the larger business by revenue, generating $518M annually — 2.0x CARE's $255M. UVSP is the more profitable business, keeping 17.5% of every revenue dollar as net income compared to CARE's 12.3%.

MetricCARE logoCARECarter Bankshares…UVSP logoUVSPUnivest Financial…
RevenueTrailing 12 months$255M$518M
EBITDAEarnings before interest/tax$46M$119M
Net IncomeAfter-tax profit$31M$91M
Free Cash FlowCash after capex$30M$92M
Gross MarginGross profit ÷ Revenue+61.7%+61.0%
Operating MarginEBIT ÷ Revenue+15.7%+21.9%
Net MarginNet income ÷ Revenue+12.3%+17.5%
FCF MarginFCF ÷ Revenue+12.5%+18.7%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+8.3%+23.1%
UVSP leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

UVSP leads this category, winning 5 of 6 comparable metrics.

At 12.3x trailing earnings, UVSP trades at a 34% valuation discount to CARE's 18.7x P/E. On an enterprise value basis, UVSP's 7.5x EV/EBITDA is more attractive than CARE's 16.3x.

MetricCARE logoCARECarter Bankshares…UVSP logoUVSPUnivest Financial…
Market CapShares × price$580M$1.1B
Enterprise ValueMkt cap + debt − cash$653M$902M
Trailing P/EPrice ÷ TTM EPS18.69x12.27x
Forward P/EPrice ÷ next-FY EPS est.4.76x11.15x
PEG RatioP/E ÷ EPS growth rate0.84x
EV / EBITDAEnterprise value multiple16.33x7.53x
Price / SalesMarket cap ÷ Revenue2.28x2.13x
Price / BookPrice ÷ Book value/share1.40x1.18x
Price / FCFMarket cap ÷ FCF18.23x11.39x
UVSP leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

UVSP leads this category, winning 7 of 9 comparable metrics.

UVSP delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $8 for CARE. UVSP carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs UVSP's 7/9, reflecting strong financial health.

MetricCARE logoCARECarter Bankshares…UVSP logoUVSPUnivest Financial…
ROE (TTM)Return on equity+7.6%+9.8%
ROA (TTM)Return on assets+0.7%+1.1%
ROICReturn on invested capital+5.7%+6.5%
ROCEReturn on capital employed+1.5%+8.8%
Piotroski ScoreFundamental quality 0–987
Debt / EquityFinancial leverage0.43x0.37x
Net DebtTotal debt minus cash$73M-$202M
Cash & Equiv.Liquid assets$105M$554M
Total DebtShort + long-term debt$179M$352M
Interest CoverageEBIT ÷ Interest expense0.39x0.60x
UVSP leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CARE and UVSP each lead in 3 of 6 comparable metrics.

A $10,000 investment in CARE five years ago would be worth $18,800 today (with dividends reinvested), compared to $14,756 for UVSP. Over the past 12 months, CARE leads with a +68.4% total return vs UVSP's +32.7%. The 3-year compound annual growth rate (CAGR) favors UVSP at 33.5% vs CARE's 24.8% — a key indicator of consistent wealth creation.

MetricCARE logoCARECarter Bankshares…UVSP logoUVSPUnivest Financial…
YTD ReturnYear-to-date+34.7%+21.5%
1-Year ReturnPast 12 months+68.4%+32.7%
3-Year ReturnCumulative with dividends+94.6%+138.1%
5-Year ReturnCumulative with dividends+88.0%+47.6%
10-Year ReturnCumulative with dividends+111.1%+141.5%
CAGR (3Y)Annualised 3-year return+24.8%+33.5%
Evenly matched — CARE and UVSP each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CARE and UVSP each lead in 1 of 2 comparable metrics.

CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than UVSP's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricCARE logoCARECarter Bankshares…UVSP logoUVSPUnivest Financial…
Beta (5Y)Sensitivity to S&P 5000.56x1.01x
52-Week HighHighest price in past year$26.41$39.00
52-Week LowLowest price in past year$15.37$27.91
% of 52W HighCurrent price vs 52-week peak+99.1%+99.4%
RSI (14)Momentum oscillator 0–10075.268.5
Avg Volume (50D)Average daily shares traded273K178K
Evenly matched — CARE and UVSP each lead in 1 of 2 comparable metrics.

Analyst Outlook

UVSP leads this category, winning 1 of 1 comparable metric.

Wall Street rates CARE as "Buy" and UVSP as "Hold". Consensus price targets imply 3.2% upside for CARE (target: $27) vs -12.3% for UVSP (target: $34). UVSP is the only dividend payer here at 2.27% yield — a key consideration for income-focused portfolios.

MetricCARE logoCARECarter Bankshares…UVSP logoUVSPUnivest Financial…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$27.00$34.00
# AnalystsCovering analysts46
Dividend YieldAnnual dividend ÷ price+2.3%
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS$0.88
Buyback YieldShare repurchases ÷ mkt cap+3.4%+3.1%
UVSP leads this category, winning 1 of 1 comparable metric.
Key Takeaway

UVSP leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.

Best OverallUnivest Financial Corporati… (UVSP)Leads 4 of 6 categories
Loading custom metrics...

CARE vs UVSP: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CARE or UVSP a better buy right now?

For growth investors, Carter Bankshares, Inc.

(CARE) is the stronger pick with 6. 2% revenue growth year-over-year, versus 3. 6% for Univest Financial Corporation (UVSP). Univest Financial Corporation (UVSP) offers the better valuation at 12. 3x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CARE or UVSP?

On trailing P/E, Univest Financial Corporation (UVSP) is the cheapest at 12.

3x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CARE or UVSP?

Over the past 5 years, Carter Bankshares, Inc.

(CARE) delivered a total return of +88. 0%, compared to +47. 6% for Univest Financial Corporation (UVSP). Over 10 years, the gap is even starker: UVSP returned +141. 5% versus CARE's +111. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CARE or UVSP?

By beta (market sensitivity over 5 years), Carter Bankshares, Inc.

(CARE) is the lower-risk stock at 0. 56β versus Univest Financial Corporation's 1. 01β — meaning UVSP is approximately 80% more volatile than CARE relative to the S&P 500. On balance sheet safety, Univest Financial Corporation (UVSP) carries a lower debt/equity ratio of 37% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CARE or UVSP?

By revenue growth (latest reported year), Carter Bankshares, Inc.

(CARE) is pulling ahead at 6. 2% versus 3. 6% for Univest Financial Corporation (UVSP). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to 22. 5% for Univest Financial Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CARE or UVSP?

Univest Financial Corporation (UVSP) is the more profitable company, earning 17.

5% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UVSP leads at 21. 9% versus 15. 7% for CARE. At the gross margin level — before operating expenses — CARE leads at 61. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CARE or UVSP more undervalued right now?

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 4. 8x forward P/E versus 11. 1x for Univest Financial Corporation — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 2% to $27. 00.

08

Which pays a better dividend — CARE or UVSP?

In this comparison, UVSP (2.

3% yield) pays a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.

09

Is CARE or UVSP better for a retirement portfolio?

For long-horizon retirement investors, Univest Financial Corporation (UVSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

01), 2. 3% yield, +141. 5% 10Y return). Both have compounded well over 10 years (UVSP: +141. 5%, CARE: +111. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CARE and UVSP?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CARE is a small-cap quality compounder stock; UVSP is a small-cap deep-value stock. UVSP pays a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CARE

Steady Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

UVSP

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 10%
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CARE and UVSP on the metrics below

Revenue Growth>
%
(CARE: 6.2% · UVSP: 3.6%)
Net Margin>
%
(CARE: 12.3% · UVSP: 17.5%)
P/E Ratio<
x
(CARE: 18.7x · UVSP: 12.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.